Abstract
Within the biofilm, the bacteria use cell-to-cell communication systems to pool their activities and act in a multicellular organized manner. One such activity is to launch their arsenal of virulence factors at the strategically right moment, and hence coordinate the progressive attack on the host. This process is termed quorum sensing (QS), whereby bacteria produce diffusible chemical signals (autoinducers) that interact with specific receptors on itself and on neighboring cells, which in turn regulate the expression of specific target genes. By integrating this with other environmental stimuli, bacteria are capable of exhibiting complex responses and take part in sophisticated interactions, allowing them to survive in most adverse environments. This chapter describes the molecular mechanisms of QS in Gram-negative and gram positive bacteria, and QS in a biofilm, leading to what is described in subsequent chapters that QS is a highly attractive target for therapy against biofilm chronic infections.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Quorum Sense
- Quorum Sense System
- Quorum Sense Signal
- Pseudomonas Quinolone Signal
- Actinobacillus Actinomycetemcomitans
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Well within the biofilm, the bacteria use cell-to-cell communication systems to pool their activities and act in a multicellular organized manner. One such activity is to launch their arsenal of virulence factors at the strategically right moment and hence coordinate the progressive attack on the host. The view of bacterial biofilms as sanctuaries in a hostile environment has gained momentum over the last decade. Bacteria released from these protected areas are then able to spark systemic infections (Costerton et al. 2003). The ability of coordinating gene expression in accordance with population density and hence to act as a group is a process termed quorum sensing (QS) (Fuqua et al. 1994; Withers et al. 2001) (see Fig. 1). The amount of bacteria needed to activate QS-controlled genes are known as the “quorum” or the “quorum size,” reflecting the number of individual cells needed to make a qualified decision.
The underlying mechanism of QS is the production of diffusible chemical signal molecules by the bacteria (autoinducers) that interact with specific receptors on self and on neighboring cells, which in turn regulate expression of specific target genes. By integrating this with other environmental signals and stimuli, bacteria are capable of exhibiting complex responses and taking part in sophisticated interactions (Gray 1997).
QS is implicated in the regulation of phenotypes that are also involved in interactions with higher organisms. These interactions can be beneficial to the host, or they can be pathogenic. From an evolutionary point of view, it makes sense that the underlying factors are produced only when the bacterial population is sufficiently large to confer a significant effect (Velicer 2003). QS systems form the command line of opportunistic pathogens such as P. aeruginosa and S. aureus (Winzer and Williams 2001). Expressing the battery of antigenic determinants such as host-damaging virulence factors only when the bacterial population has reached a high level is believed to be a “stealthy strategy”; by the time the host organism realizes it is under attack, it has been left with a poor possibility of mounting an effective defense against the intruder (Donabedian 2003; de Kievit and Iglewski 2000; Parsek and Greenberg 2000).
To date, several types of QS systems are known: one for gram-positive bacteria relying on polypeptides (Abraham 2006; Balaban et al. 1998; Waters and Bassler 2005) and another for gram-negative bacteria mediated by N-acyl homoserine lactone (AHL) derivatives (Eberhard et al. 1981; Nasser and Reverchon 2007). A third type of QS system, AI-2, has been proposed as a global signaling system common to all bacteria (Winans and Bassler 2002; Waters and Bassler 2005).
AHL-mediated Quorum Sensing in Gram-negative Bacteria11–4
The core elements of all AHL-based QS systems are a gene termed the luxI homolog encoding an AHL synthetase and a luxR homolog encoding the signal receptor protein, which also acts as a response regulator. At low cell densities, the luxI homolog is expressed constitutively at a low level; hence, AHLs are synthesized in small quantities, which slowly accumulate in the environment around the bacteria, depending on the diffusion restraints (Fuqua and Greenberg 2002). Accordingly, there is a correlation between AHL concentration and population density – more cells results in more signal molecules per volume. Work on the Vibrio fischeri QS system has given rise to a “QS dogma,” which states that when a sufficient population density has been attained, QS target genes become activated. The signal molecules bind to the LuxR homolog receptor proteins, inducing a conformational change and allowing the proteins to form dimers or multimers. This in turn enables the receptor multimer to bind to DNA and act as a transcriptional regulator. The activity of a QS-controlled gene is determined by the concentration of activated LuxR homolog multimer, which in turn is dependent on the concentration of AHL signal, which again is dependent on the population size/density. In other words, activation of QS-controlled genes relies on both the concentration of AHL signal molecules and the amount of available LuxR homolog receptor protein.
Gram-negative bacteria that are unable to synthesize signal molecules are still able to perceive and respond to the AHL signal molecules. These include Salmonella typhimurium and Escherichia coli, which both posses a gene, sdiA, that is a LuxR homolog. The SdiA receptor is responsive to 3-oxo-C6 and 3-oxo-C8 signal molecules, enabling the bacteria to sense the presence of other AHL-producing bacteria in a mixed community and to respond to the AHL signal molecules.
Multiple Quorum-sensing Systems Regulate Virulence
The model gram-negative bacterium P. aeruginosa produces two QS signals: N-(3-oxododecanoyl)-l-homoserine lactone [OdDHL, synthesized by LasI and sensed by LasR (Gambello and Iglewski 1991; Ochsner et al. 1994)] and N-butanoyl-l-homoserine lactone [BHL, synthesized by RhlI and sensed by RhlR (Pearson et al. 1994)]. With respect to function, they are organized in a hierarchical manner, the former controlling the expression of the latter. This allows for further fine-tuning of the responses of QS target genes. Sequence analysis suggests that these systems have been acquired independently rather than arising by endogenously gene duplication – the las system in P. aeruginosa shows no affiliation with the rhl system. This indicates that horizontal gene transfer is a mechanism for the spread of, and is important for the prevalence of, QS controllers.
AHL Signal Generation
The LuxI and homologs direct synthesis of the AHLs. The signal molecules consist of an invariable highly conserved lactone ring and a variable acyl side chain [Fig. 2a,b (AHL or AI-1)]. The side chains differ in length (2–18 carbon atoms), but all side chains contain a keto group on the C1 position and various degrees of substitution on C3. Molecules that carry a keto oxygen on the C3 carbon are referred to as oxo-HSLs. A few rare AHL species contain a hydroxyl substitution on the C3 position, whereas others posses a double bond in the side chain.
The LuxI synthases use S-adenosylmethionine (SAM) as HSL donor and acyl-acyl carrier protein (acyl-ACP) or acyl-coenzyme A from the fatty acid synthesis complex as acyl donor (Parsek et al. 1999). The different side chains probably reflect variations in acyl-ACP specificity. Conversely, the specificity for SAM must be similar for all LuxI homologs as the HSL ring is invariable (Watson et al. 2002).
After synthesis, the signal molecules enter the surrounding environment, either by passive diffusion in the case of C4 HSL or active efflux in the case of 3-oxo-C12 HSL (Pearson et al. 1999; Waters and Bassler 2005).
Signal Reception and Response Regulation
Perception of the signal molecules and subsequent gene regulation are performed by the LuxR homologs. LuxR homolog proteins contain two functional domains, the AHL-binding N-terminal and a DNA-binding C-terminal (Hanzelka and Greenberg 1995; Egland and Greenberg 2001; Koch et al. 2005). In LuxR, it has been found that the C-terminal third part of the 250-residue protein has a helix-turn-helix motif able to bind to DNA and is able to activate LuxR-controlled genes independently of AHL (Choi and Greenberg 1991). This has led to the model that the N-terminal two-thirds of the protein quenches the DNA-binding activity. Another truncated LuxR, consisting of the N-terminal part, has been shown to bind AHL and in turn activates the C-terminal part (Hanzelka and Greenberg 1995). Activated LuxR homologs are thought to bind as dimers capable of interacting with the promoter regions of QS-controlled genes (Vannini et al. 2002; Zhang et al. 2002b; Ledgham et al. 2003). The lux box, where the dimer binds, is a palindromic sequence centered −42.5 bp upstream of the luxI start codon. The dimer overlaps the −35 region and acts as an ambidextrous activator of transcription (Egland and Greenberg 1999). Located at this position, the LuxR dimer interacts with the alpha-subunit C-terminal domain of RNA polymerase, where two residues of the subunit interact directly with the C-terminal part of LuxR (Finney et al. 2002; Johnson et al. 2003). Alanine mutation scanning of the N-termini of LuxR has provided evidence for a direct correlation between the binding of LuxR to the lux box and activation of QS-controlled target genes (Trott and Stevens 2001; Egland and Greenberg 2001). It appears that each LuxR homolog protein has its own lux box type of binding site, and similar binding sites have been identified for LasR and RhlR in P. aeruginosa. These las and rhl boxes are important for the expression of QS target genes such as lasB, hcnA, and others (Whiteley and Greenberg 2001). Two las boxes are located upstream of the lasB gene; one is located directly upstream of the transcriptional initiation site, whereas the other is placed 102 bp upstream. Both participate in controlling lasB expression (Rust et al. 1996; Fukushima et al. 1997).
AI-2 Signaling
AI-2 was initially identified for its control of the expression of bioluminescence in the marine bacterium Vibrio harveyi (Bassler et al. 1993) and was identified as a furanosyl borate diester. The AI-2 (Fig. 2c,d) and its synthase LuxS have been identified in a few bacterial species (Chen et al. 2002; Miller et al. 2004, Schauder et al. 2001; Xavier and Bassler 2005). However, the presence of luxS analogs in more than 55 species indicates that it is widely used in cell-to-cell signaling (Vendeville et al. 2005) to regulate genes specifying diverse functions, such as those encoding virulence factors in Actinobacillus actinomycetemcomitans, enterohemorrhagic E. coli (EHEC) O157:H7, P. gingivalis, Streptococcus pyogenes, Vibreio cholerae, and V. vulnificus; motility in Campylobacter jejuni, EHEC O157:H7, and enteropathogenic E. coli O127:H6; cell division in E. coli W3110 and EHEC O157:H7; antibiotic production in Photorhabdus luminescens; and biofilm formation and carbohydrate metabolism in Streptococcus gordonii (Xavier and Bassler 2005; Gonzalez Barrios et al. 2006; Ren et al. 2004b; Sperandio et al. 1999). In S. aureus, functional analysis of luxS/AI-2 reveals a role in metabolism but not quorum sensing, in which inactivation of luxS did not affect virulence-associated traits such as production of hemolysins and extracellular proteases, biofilm formation, and the agr QS signaling system (Doherty et al. 2006).
Other Quorum-signaling Systems
At least two additional QS systems have been identified in gram-negative bacteria. These include autoinducer 3 (AI-3), which is associated with virulence regulation in EHEC O157:H7 (Sperandio et al. 2003), and the Pseudomonas quinolone signal (PQS), which is associated with P. aeruginosa (Mashburn and Whiteley 2005). AI-3 is associated with luxS homologs in EHEC O157:H7, but the signal itself is hydrophobic and thus chemically distinct from the polar AI-2 signals (Sperandio et al. 2003). AI-3 is also biologically distinct from AI-2. During EHEC pathogenesis, both AI-3 and host epinephrine, but not AI-2, stimulate expression of the locus of enterocyte effacement (LEE) genes and thus provide evidence of bacteria and host cross-talk during this infection (Walters and Sperandio 2006). PQS molecules are quite hydrophobic and have been shown to be transported between cells by outer membrane vesicles. There is also strong evidence that the PQS actually induces the formation of these vesicles through interference with Mg2+ and Ca2+ ions in the outer membrane (Mashburn and Whiteley 2005). In a recent review (Mashburn-Warren and Whiteley 2006), it was suggested that membrane vesicles may represent a mechanism for interkingdom signaling in the plant rhizosphere.
AHL QS Interference with the Host Immune System
Eukaryotic cells communicate by means of hormones and prostaglandins that are structurally related to the bacterial AHLs, and it has been investigated whether the signal molecules produced by P. aeruginosa are able to interact directly with the human host cells (Smith and Iglewski 2003). Indeed, 3-oxo-C12 HSL was found to inhibit lymphocyte proliferation and tumor necrosis factor alpha (TNF-α) production by macrophages. In addition, IgE production, which is stimulated by interleukin-4, was found to be upregulated by 3-oxo-C12 HSL. Furthermore, the presence of the AHL signal molecule downregulated production of interleukin 12 (a Th-1 response promoting signal). As a consequence, a Th-2 response is encouraged (Telford et al. 1998). In contrast, other researchers found that 3-oxo-C12 HSL activates T-cells to produce interferon-γ, an inflammatory cytokine that promotes a Th-1 environment (Smith et al. 2002a). These discrepancies probably reflect biases in the underlying immune response. In C57B1/6 mice, which are Th-1 biased, 3-oxo-C12 HSL was found to increase interferon-γ, thereby promoting a Th-1-dominated response. Conversely, if BALB/C mice biased for Th-2 were used, the P. aeruginosa signal molecules increased production of interleukin-4, favoring a Th-2-dominated response (Moser et al. 1997). In both cases, the underlying immune response bias was accentuated by 3-oxo-C12 HSL (Ritchie et al. 2003). Production of cyclooxygenase 2 was markedly increased in human lung fibroblasts through stimulation of the transcription factor NF-κB. PGE2, which induces mucus secretion, vasodilatation, and edema, was also produced in higher amounts when the cells were exposed to 3-oxo-C12 HSL (Smith et al. 2002b). AHL signal molecules also inhibit ATP and UTP-induced chloride secretion by submucosal tracheal serous gland cells from cystic fibrosis patients. Normally, the nucleosides lead to relaxation of the bronchia, which, in turn, promotes bacterial clearance. This ability of the 3-oxo-C12 HSL signal molecule to modulate the immune response has promoted research into generating analogs that can be used as treatment for TNF-alpha-driven immunological diseases such as psoriasis, rheumatoid arthritis, and type 1 diabetes (Chhabra et al. 2003).
Other eukaryotes also respond to the presence of AHL signal molecules. The model legume plant Medicago truncatula, a close relative of alfalfa, was found to produce elevated amounts of flavonoids in response to 3-oxo-C12 HSL. Interestingly, the plant also begins to secrete compounds that mimic AHL molecules when it encounters QS bacteria such as P. aeruginosa (Mathesius et al. 2003).
Similar relationships between QS and infection have been established for several opportunistic pathogens, including Serratia liquefaciens (Eberl et al. 1996, 1999), Chromobacterium violaceum (Brito et al. 2004), Burkholderia cepacia (Wopperer et al. 2006), and Yersinia species (Atkinson et al. 2006), all of which cause infections in humans. Other pathogens such as V. anguliarum, which causes the deadly infection vibriosis in fish, and the plant pathogens Agrobacterium tumefaciens (Sheng and Citovsky 1996) and E. caratovora (Whitehead et al. 2002) also employ QS to control infection and virulence. Bacteria such as S. proteamaculans B5a and Enterobacter agglomerans B6a, which causes food-quality deterioration, utilize QS to control expression of exoenzymes that are involved in decay (Gram et al. 1999, Christensen et al. 2003).
Inhibition of QS would thus not only be beneficial in a clinical context but could possibly also be applied in aquaculture, agriculture, and food preservation.
Quorum Sensing in Gram-positive Bacteria4
Quorum sensing in gram-positive bacteria regulates a number of physiological activities, including those involving pathogenesis and biofilm formation. Examples are competence development in Streptococcus pneumoniae and S. mutans, antibiotic biosynthesis in Lactococcus lactis and virulence in staphylococci.
Gram-positive bacteria communicate using polypeptides as autoinducers and two-component or phosphorelay systems for signaling (Hoch and Varughese 2001). The release of the polypeptides from the cells is mediated in many cases by dedicated exporters. In most cases, signal processing and modification are concomitant with signal release. In many peptide QS systems, signals are cleaved from larger precursor peptides, which are then modified to contain lactone or thiolactone rings, lanthionines, or isoprenyl groups (Ansaldi et al. 2002; Mayville et al. 1999; Nakayama et al. 2001). QS in gram-positive bacteria has been well reviewed (e.g., Walters and Bassler 2005, Abraham 2006). Here we will focus on QS in staphylococci, whose inhibitors have extensively been tested in vivo (see the chapter In Vivo Studies: Inhibiting Biofilm-Associated Bacterial Infections Using QSIs). Refer to the chapter Quorum Sensing in Streptococci for information on that topic.
Quorum Sensing in S. aureus
S. aureus pathogenesis is regulated by two QS systems (Balaban et al. 2001; Gov et al. 2004, Korem et al. 2005). As in P. aeruginosa, the two QS systems are organized in a hierarchical manner, the former controlling the expression of the latter. This apparently allows for further fine-tuning of the responses of QS target genes.
The two QS systems that have been described to date for S. aureus (Balaban et al. 2001) will be referred to herein as staphylococcal quorum-sensing 1 (SQS 1) and staphylococcal quorum-sensing 2 (SQS 2). SQS 1 consists of the autoinducer RNAIII-activating protein (RAP) and its target molecule TRAP (Balaban et al. 1998, 2001). SQS 1 induces the synthesis of the second system, SQS 2, which consists of the components of the agr system, including autoinducing peptide (AIP) and its sensor AgrC (Lyon et al. 2000). The two systems interact with one another to collectively regulate the expression of virulence factors (Balaban et al. 2001; Korem et al. 2005).
The notion that more than one QS system regulates virulence in staphylococci had been controversial, and it was suggested that only one QS system regulates S. aureus pathogenesis – the one encoded by agr (Novick 2003). It is now, however, very clear that this is not the case and that SQS 1 in fact regulates SQS 2 (Korem et al. 2005). This phenomenon is not surprising in view of the fact that multiple systems are known to regulate necessary biological functions both in gram-negative and gram-positive bacteria (e.g., Miller and Bassler 2001; March and Bentley 2004; Gambello and Iglewski 1991; Ochsner et al. 1994; Pearson et al. 1994).
Components of SQS 1
RAP is the autoinducer of SQS 1. RAP is a 277AA protein that activates the agr by inducing the phosphorylation of TRAP (Balaban et al. 1998, 2001; Korem et al. 2003; Yang et al. 2003). From its sequence, RAP is predicted to be an ortholog of the 50S ribosomal protein L2, which is encoded by the gene rplB found in all eubacterial genomes known to date. Recombinant RAP applied to the cells activates the synthesis of RNAIII (which is encoded by the agr) like the native RAP molecule that is secreted, confirming that L2 has extraribosomal functions (Korem et al. 2003). Inhibiting RAP by anti-RAP antibodies or by RAP-binding peptides suppresses infections in vivo (Balaban et al. 1998; Yang et al. 2003). (Refer to the chapter In Vivo Studies: Inhibiting Biofilm-Associated Bacterial Infections Using QSIs.)
TRAP is the target protein of RAP and is a master regulator of S. aureus pathogenesis. It is a 167-residue-long protein that is histidine-phosphorylated in the presence of RAP (Balaban et al. 2001). TRAP expression is constitutive, but its phosphorylation is regulated by RAP and reaches peak phosphorylation in the midexponential phase of growth. Phosphorylated TRAP then leads to agr expression, and the components of SQS 2 are made (Gov et al. 2004). (See below.) TRAP is highly conserved among staphylococcal strains and species and contains three conserved histidine residues that are phosphorylated and are essential for its activity (Gov et al. 2004; Korem et al. 2005). TRAP orthologs are found in other gram-positive bacteria including Bacillus (Ivanova1 et al. 2003) and Listeria. Although the sequence identity between TRAP orthologs is low, their predicted secondary structure is very similar, as is their gene organization (Kiran et al., unpublished data). TRAP-like proteins may thus represent a novel general class of signal transducers in gram-positive bacteria.
Functional genomics studies (Korem et al. 2005) indicate that in the absence of TRAP expression or phosphorylation (TRAP–), multiple regulatory systems are disrupted, such as the global regulatory locus agr (agrABCD and hld [RNAIII]); sarH2, otherwise known as sarU (Manna and Cheung 2003); and most, if not all, virulence factors known to date. Those include alpha, beta, gamma, and delta hemolysin; triacylglycerol lipase precursor; glycerol ester hydrolase; hyaluronate lyase precursor; staphylococcal serine protease (V8 protease); cysteine protease precursor; cysteine protease; staphopain-cysteine proteinase; 1-phosphatidylinositol phosphodiesterase; zinc metalloproteinase aureolysin precursor; holing-like proteins; and capsular polysaccharide synthesis enzymes (Korem et al. 2005). In the case of genes involved in bacterial adhesion and consequent biofilm formation, the only overexpressed genes found when TRAP function is disrupted are those encoding for protein A, fibrinogen-binding protein, and Ser-Asp rich fibrinogen-binding bone-sialoprotein-binding protein. There is, however, no evidence that these proteins independently contribute to pathogenesis. No upregulation of other known genes encoding for adhesion molecules has been observed, such as fibronectin-binding protein, collagen-binding protein, elastin-binding protein, clumping factor A, extracellular fibrinogen-binding protein, and extracellular adherence protein.
Finally, in the absence of TRAP expression or phosphorylation, the level of expression of genes required for biofilm survival is reduced, such as ArcABC (arginine deaminase, ornithine transcarbamoylase, carbamate kinase), UreABC (urease alpha, beta, gamma subunits), UreDEFG (urease accessory proteins), PyrR (pyrimidine operon repressor), PyrP (uracil permease), PyrB (aspartate transcarbamoylase chain A), PyrC (dihydroorotase), CarA (carbamoyl-phosphate synthase small chain), and CarB (carbamoyl-phosphate synthase large chain) (Korem et al. 2005; Balaban et al. 2005). These proteins are necessary for the persistence of the bacteria within a biofilm, requiring an adaptive response that limits the deleterious effects of the reduced pH associated with anaerobic growth conditions (Beenken et al. 2004).
Functional genomics studies can easily explain that in the absence of TRAP phosphorylation, the ability of the bacteria to produce toxins, to attach to host cells or foreign material, to form a biofilm, and to survive within the host is seriously compromised; therefore, when TRAP is not expressed or phosphorylated (using anti-TRAP antibodies or peptides (see below and the chapter In Vivo Studies: Inhibiting Biofilm-Associated Bacterial Infections Using QSIs), the bacteria do not adhere, do not form a biofilm, do not express toxins, and do not cause disease (Dell’Acqua et al. 2004; Balaban et al. 2000, 2003a,b, 2004, 2005; Cirioni et al. 2003, 2006, 2007; Giacometti et al. 2003, 2005; Gov et al. 2004; Yang et al. 2005; Vieira-da-Motta 2001; Anguita-Alonso et al. 2006).
TRAP represents a novel class of signal transducers in gram-positive bacteria because it does not contain any conserved domains specific for two-component or phosphorelay systems (Han et al. 2005). QS in bacteria typically involves phosphorylation in a two-component system. The classic two-component system is composed of two proteins, the sensor kinase, which is histidine-phosphorylated, and the effector protein, which is aspartic-acid-phosphorylated. The sensor typically contains a transmembrane as well as a kinase domain (Perraud et al. 1999). Like typical sensors, TRAP is histidine-phosphorylated (Balaban et al. 2001; Gov et al. 2004), and studies indicate that it is membrane associated and can be used as a vaccine (Yang et al. 2005). However, TRAP lacks both a typical kinase domain and a predicted transmembrane region. This suggests that TRAP may be associated with the membrane by anchoring of hydrophobic surface residues or by binding to an integral membrane protein. A possible candidate may be OpuCA, discovered by a two-hybrid system (Kiran et al., unpublished data). OpuCA is encoded by the opuC operon that is highly conserved, is known as an ABC transporter, and thus is hypothesized to act upstream of TRAP. The type of interaction that OpuCABCD has with TRAP (anchoring?) or with the QS regulators RAP, AIP, and RIP is not yet known.
Interestingly, recombinant RAP or its inhibitor RIP (see the chapter Quorum-Sensing Inhibitory Compounds) were added to recombinant TRAP and shown to activate (RAP) or inhibit (RIP) the phosphorylation of TRAP in vitro, in the absence of any other cellular components. This further confirms the working hypothesis that RAP activates and RIP inhibits TRAP phosphorylation and further suggests that TRAP may in fact be a histidine kinase (Kim, personal communications).
One of the regulatory genes that is distinctly regulated by TRAP is sarH2 (known also as sarU) (Balaban et al. 2005). SarU, a positive transcriptional activator of agr expression, encodes a 247-residue polypeptide and is a member of the SarA family of proteins. It has conserved basic residues within the helix-turn-helix motif and within the beta hairpin loop, which are two putative DNA-binding domains within this protein family (Manna and Cheung 2003). Of note is that insertions in sarH2 have diminished the ability of the S. aureus strain Newman to kill worms (Bae et al. 2004), suggesting that its role in pathogenesis. SarH2 (SarU) may act as one of the downstream components in the TRAP system, regulating the expression of agr (see below). This, however, needs to be confirmed experimentally because sarH2 is not conserved among strains.
Points of controversy
Lately it has been suggested that TRAP does not regulate the agr (Shaw et al. 2007; Tsang et al. 2007) because when the authors deleted traP, agr activity was still intact. These results will need to be confirmed as the authors have not yet shown that the mutants do not contain an active TRAP molecule (by standard in vivo phosphorylation assays and by western blotting). Interestingly, one of the two strains used, UAMS-1, is non-hemolytic although it is a virulent musculoskeletal isolate, suggesting that perhaps its virulence is not toxin related and maybe virulence of such strains does not involve TRAP. In fact, global transcriptional differences between these clinical isolates and laboratory strains have been documented (Cassat et al. 2006). It is too early to say whether these strains represent the norm or not. Luckily, virulence studies using laboratory strains have in fact resulted in clinical applications using clinical isolates (see the chapters In Vivo Studies: Inhibiting Biofilm-Associated Bacterial Infections Using QSIs and Clinical Wound Healing Using Signal Inhibitors).
It has also been suggested that the non-virulent agr– minus phenotype found in the TRAP– mutant are seen only because of a nonsense mutation in the agrA locus (Adhikari et al. 2007). This nonsense mutation was not found in TRAP– strains described in Korem et al. 2005, but other nonsense mutations were found in some of the freezer stocks (Balaban et al., in preparation), suggesting that when TRAP is inactivated, multiple nonsense mutations can occur in agr (and possibly other loci) more readily. Interestingly, ClpP is not expressed when TRAP or YhgC (the TRAP-like protein in Bacillus) are mutated (Kiran et al., in preparation). ClpP proteases were shown to be important for expression of various regulons involved in virulence (agr), oxidative stress response, autolysis, and DNA repair (Michel et al. 2006). Put together, these results suggest that in the absence of TRAP, not only virulence is downregulated but also DNA repair is impaired, which can lead to deleterious multiple agr mutations (Adhikari et al. 2007). Such mutants cannot survive in vivo because of the lack of expression of virulence factors necessary for in vivo survival. But in vitro, in the absence of adverse conditions, such mutants can survive and be detected. Thus, TRAP not only regulates the production of virulence factors but also other genes necessary for bacterial survival in the host, making TRAP a very attractive target for therapy (see the chapters Quorum-Sensing Inhibitory Compounds and In Vivo Studies: Inhibiting Biofilm-Associated Bacterial Infections Using QSIs).
Components of SQS 2
SQS 2 encompasses the products of the agr system. The chromosomal agr operons, active from the midexponential phase of growth, encode two divergently transcribed transcripts, RNAII and RNAIII (Novick et al. 1993, 1995). RNAII is a polycistronic transcript that encodes AgrB, AgrD, AgrC, and AgrA (Ji et al. 1997; Qiu et al. 2005; Zhang and Ji 2004; Novick et al. 1995; Lina et al. 1998; Koenig et al. 2004). RNAIII is a polycistronic transcript, coding for delta hemolysin and acting as a regulatory RNA molecule that upregulates the expression of multiple exotoxins (Novick et al. 1993).
Agr-autoinducing Peptide (AIP)
AIP is processed from AgrD. AgrD sequences from various staphylococcal species are remarkably divergent, with only four identical amino acids (Qiu et al. 2005). The AIP sequence is in the middle of the AgrD sequence that is preceded by the N-terminal amphipathic helix and followed by a highly hydrophilic C-terminal region. The processing of AgrD to generate mature AIP involves the proteolytic cleavages at two processing sites, the thioester (or ester) bond formation, and the secretion of the mature AIP. The mature AIPs isolated so far from a number of staphylococcal species are seven to nine amino acids in length, and all are thiolactone molecules containing a 5-amino-acid ring linked by a thioester bond formed between the sulfhydryl group of a conserved cysteine residue and the carboxyl group of the C-terminal amino acid, except for the Staphylococcus intermedius AIP, in which a lactone molecule contains an ester bond formed between the hydroxyl group of a serine residue (in place of the cysteine residue that is conserved among other AIPs) and the carboxyl group of the C-terminal residue (Qiu et al. 2005; Lyon et al. 2002; Mayvelle et al. 1999).
A polymorphism in the amino acid sequence of the AIP and its corresponding receptor AgrC divides S. aureus strains into four major groups. Within a given group, each strain produces a peptide that can activate the agr response in the other strains, whereas the AIPs belonging to different groups are usually mutually inhibitory. Limited in vivo studies have been carried out using inhibitory AIPs (refer to the section on inhibitors to SQS 2 in the chapter Quorum-Sensing Inhibitory Compounds), but their clinical significance remains unclear.
AgrB
AgrB protein is a putative cysteine endopeptidase and a transporter, facilitating the export of the processed AgrD peptide (Qiu et al. 2005). AgrB is a membrane protein with six transmembrane segments, including four transmembrane helices and two highly hydrophilic regions (Zhang et al. 2002a). Like AgrD and AgrC, AgrB sequenced from various staphylococcal species are also divergent, except for the N-terminal region located in the cytoplasm and the two highly hydrophilic regions that are proposed to be in the membrane (Zhang et al. 2002a). It is likely that all AgrBs are structurally and functionally similar and that the mechanisms of processing AgrD and of secreting the mature AIP by AgrBs are the same or similar, even though the AgrD propeptides are different and the interaction between AgrB and AgrD is specific (Zhang et al. 2004).
AgrC
AgrC is the receptor to AIP. AgrC is a membrane protein with its N-terminal half integrated into the cytoplasmic membrane and is the AIP binding site (Lina et al. 1998; Lyon et al. 2002). Its C-terminal half is located in the cytoplasm and possesses histidine kinase activity (Lina et al. 1998). The N-terminal halves are divergent, and the C-terminal halves are highly conserved. This reflects the fact that the AgrCs are activated only by their cognate AIPs but are inhibited by heterologous AIPs. Based on the AIP cross-activation and cross-inhibition activities, four specificity groups of S. aureus and three groups of S. epidermidis have been identified. Upon the binding of AIP, AgrC is autophosphorylated (Lina et al. 1998), the phosphoryl group of the phosphorylated AgrC is transferred to AgrA, and phosphorylated AgrA activates the transcription of RNAIII (Koenig et al. 2004) (see below).
AgrA
AgrA is the regulator that is part of the AgrC/AgrA two component system. Once phosphorylated, it shows high-affinity binding to the RNAIII-agr intergenic region, where binding is localized to a pair of direct repeats in the P2 and P3 promoter regions of the agr locus, consistent with the function of AgrA as a response regulator (Koenig et al. 2004) that activates the production of RNAIII (see below).
RNAIII
RNAIII is the actual regulator that activates the expression of genes encoding secreted virulence factors. RNAIII is a 512-nt-long mRNA, affecting expression of multiple genes either directly or indirectly. RNAIII also encodes for the toxin δ-hemolysin, once translated at the postexponential phase of growth (Balaban and Novick 1995a). The commonly accepted dogma is that staphylococcal genes encoding secreted proteins are activated by the presence of RNAIII, whereas genes encoding surface proteins are repressed, leading to phase variation (Novick et al. 1993; Lowy 1998). However, this was proven only for alpha-hemolysin and protein A (see below).
The structure of RNAIII suggests that it is able to form 14 different hairpins (Benito et al. 2000). Specific domains of RNAIII control the expression of different targets: The 5′-end of RNAIII positively controls the translation of hla (encoding alpha-hemolysin) by competing directly with an inhibitory intramolecular RNA secondary structure that sequesters the hla ribosome-binding site. Hybridization of RNAIII to the hla mRNA frees the ribosome-binding site and enables translation of hla (Novick et al. 1993; Morfeldt et al. 1995).
Complementation analysis suggests that the 3′-end of RNAIII is important for repression of the spa-gene that encodes the well-known IgG-binding protein, protein A (Novick et al. 1993). In this case, RNAIII is believed to function either directly or indirectly at the transcriptional level, although it is possible that RNAIII affects the stability of the spa transcript.
RNAIII levels are evident from the midexponential phase of growth and reach a maximum in late logarithmic- and stationary-phase cultures. As mentioned above, RNAIII also encodes the small peptide δ-hemolysin in its 5′-end. Intriguingly, translation of the RNAIII transcript into δ-hemolysin is delayed 1 h after the appearance of RNAIII in the midexponential phase. This inhibitory mechanism seems to involve the 3′-end of RNAIII, possibly by blocking access of the ribosome to the ribosome-binding region (Balaban and Novick 1995a).
The mechanism by which RNAIII activates or inhibits expression of the other virulence factors remains unknown. It has been shown that transcriptional activation or repression preferentially occurs at the level of transcriptional initiation rather than by affecting transcript stability. A possible scenario would be that RNAIII functions as an antirepressor by directly binding global transcriptional regulators and then sequestering them, thereby regulating the initiation of transcription at target promoters (Arvidson and Tegmark 2001; Johansson and Cossart 2003).
agr in other Bacteria
An operon termed Fas (fibronectin/fibrinogen binding/hemolytic activity/streptokinase regulator) that shows similarity to the two-component system of agr was found in Streptococcus pyogenes (Kreikemeyer et al. 2001). As with agr, the effector molecule for virulence gene expression is a small, untranslated RNA molecule (fasX), although little is known of its mode of action (Kreikemeyer et al. 2001). In addition, an analogous case was found in Clostridium perfringens, where a small, untranslated RNA [VirR-regulated-RNA (VR-RNA)] is the effector molecule of a two-component system shown to be involved in virulence gene expression (Shimizu et al. 2002). In this case, the 3′-end of VR-RNA appears to be important in mediating virulence gene regulation (Johansson and Cossart 2003).
Interaction Between the two QS Systems in Staphylococci
The two QS systems in staphylococci SQS 1 and SQS 2 interact with one another (Fig. 3) as follows: As the cells multiply and the colony grows, the cells secrete RAP, inducing the histidine-phosphorylation of its target molecule TRAP (possibly via ClpP and OpuC). The phosphorylation of TRAP leads (possibly via SarH2) to the activation of the agr (Balaban et al. 2001; Gov et al. 2004; Korem et al. 2005) in the midexponential phase of growth and thus to the synthesis of RNAII and consequently to the production of AIP and AgrC (Novick et al. 1995). AIP downregulates TRAP phosphorylation in an unknown mechanism and upregulates the phosphorylation of its receptor, AgrC (Lina et al. 1998; Balaban et al. 2001).
Phosphorylation of AgrC causes the phosphorylation of AgrA, which together with SarA and SigB (Koenig et al. 2004; Manna and Cheung 2003; Chien et al. 1999; Ziebandt et al. 2001) results in the production of RNAIII (Novick et al. 1993; Lina et al. 1998). RNAIII leads to the expression of toxic exomolecules, resulting in dissemination and disease (Lowy 1998).
Quorum Sensing and Biofilm1–4
As stated above, QS refers to the ability of the bacteria to sense the density of the surrounding bacterial population. This is done by measuring and responding to the concentration of signal molecules. In order to build up a sufficient concentration of QS autoinducers (QSA), diffusion barriers are required. A dense, mature biofilm is not completely sealed off from the surroundings, but diffusion is certainly lowered compared with the situation in a planktonic culture (Hentzer et al. 2002). The timing of induction of QS-controlled genes probably depends on several factors. The diffusion rate will be dependent on the volume of the surrounding nonbiofilm phase, the flow rate (if any) of bulk fluid outside the biofilm. Furthermore, the chemical composition of the extrapolymeric substances will influence diffusion rates. As the cell density varies in the biofilm, different sets of QS-controlled genes may be expressed in different positions or niches of the biofilm. Hence, QS-controlled genes in biofilms also exhibit a spatial expression pattern (de Kievit et al. 2001).
Indeed, QS signals can be detected in diverse environments. For example, biofilms grown on rocks in the San Marcos River in Texas have been shown to produce AHL signals (McLean et al. 1997). In a completely different setting, in the lungs of cystic fibrosis patients, signal molecules have also been found (Collier et al. 2002, Singh et al. 2000).
In the protected biofilm environment, bacteria are free to produce and secrete a battery of virulence factors. In S. aureus and P. aeruginosa, for example, many of these virulence factors are controlled by QS (Korem et al. 2005; Dunman et al. 2001; Mittal et al. 2006; Joyce et al. 2004; Wagner et al. 2003). Virulence factors, in conjunction with immune complexes and phagocytic enzymes released by the immune system, cause extensive tissue destruction and inflammation. In the case of cystic fibrosis, this tissue destruction contributes significantly to the loss of pulmonary function (Costerton et al. 1999; Donlan 2002; Donlan and Costerton 2002; Parsek and Singh 2003).
Whether QS is involved in control of the developmental pattern of P. aeruginosa biofilms is still controversial (Kjelleberg and Molin 2002), but most of these studies were done in vitro and should be taken with caution. As reported by Charlton et al. (2000a), the concentration of QS signal OdDHL is significantly higher in P. aeruginosa biofilm (632 µM) than the effluent (14 nM). Consistent with this observation, QS has been found to play a critical role in the development of P. aeruginosa biofilms (Davies et al. 1998), showing that a lasI mutant formed flat, undifferentiated biofilms. In striking contrast, Heydorn et al. (2002) demonstrated, using Comstat-assisted image analysis, that a wild-type biofilm is indistinguishable from a biofilm formed by a lasI mutant. Again, these differences may be attributed to various strains and the experimental setups employed. When a biofilm of a P. aeruginosa QS mutant was grown on glucose as the carbon source, a difference in biofilm architecture could be found using image analysis. If the carbon source was changed to citrate, no difference could be detected (Heydorn et al. 2002).
In addition to AHL, AI-2 also plays a role in biofilm formation. Deletion of luxS has been found to influence the biofilm formation of Streptococcus gordonii (Blehert et al. 2003) and S. mutans (Merritt et al. 2003), in which the bacteria no longer produced AI-2 and the biofilm had a more granular appearance. Direct addition of AI-2 induces biofilm formation in E. coli through a motility QS regulator (MqsR), which in turn regulates the two-component motility regulatory system (QseBC) and motility (Gonzalez Barrios et al. 2006).
In staphylococci, disruption of quorum sensing by mutagenesis or by inhibitory peptides (refer to section 2 in the chapter In Vivo Studies: Inhibiting Biofilm-Associated Bacterial Infections Using SQIs and to Fig. 4 in the chapter Quorum-Sensing Inhibitory Compounds) leads to suppression of biofilm formation in vivo. As shown in Fig. 4 in the chapter Quorum-Sensing Inhibitory Compounds, essentially no biofilm is formed in vivo by the TRAP– mutant (SQS 1 mutant). In comparison, only reduced biofilm is formed by agr– mutants (SQS 2 mutant), suggesting that TRAP, which acts upstream of agr, regulates multiple genes necessary for biofilm formation in vivo in addition to those regulated by agr. These studies are important because for years it had been suggested that S. aureus exists in two phases and that the switch between the two phases is regulated by RNAIII (agr). It has been suggested that in one phase, in low cell density, before agr is expressed, there is high expression of adhesion molecule, whereas in the other phase, in high cell density, after agr is expressed, there is reduced expression of adhesion molecules and, instead, increased expression of exotoxins (Lowy 1998; Novick et al. 1993). This meant that if quorum systems TRAP or agr are repressed, toxins will be repressed, but adhesion molecules will be expressed. This in turn was expected to enhance biofilm formation, thus making QS inhibitors inadequate for inhibiting biofilm-related infections in vivo and for future clinical use (Otto 2004; Vuong et al. 2000, 2003). However, functional genomics studies show that when TRAP or agr is mutated, multiple toxins are repressed, but no significant increase in expression of adhesion molecules is observed (Beenken et al. 2004; Dunman et al. 2001; Korem et al. 2005). This is in accordance with the fact that TRAP mutants that do not express agr do have reduced ability to form a biofim or infection (Gov et al. 2004) in vivo (Fig. 4). The components of SQS 1 (RAP/TRAP) are very conserved, making them especially attractive as target sites for therapy (e.g., Balaban et al. 2005 and section 2 in the chapter In Vivo Studies: Inhibiting Biofilm-Associated Bacterial Infections Using SQIs).
Whether QS is involved in forming one type of biofilm or another is probably of less importance. More interesting are the properties or function of the biofilm. Davies et al. (1998), Hentzer et al. (2003), and Bjarnsholt et al. (2005a) found a link between biofilm tolerance against various antibiotics, biocides, peroxide, and QS. Biofilms formed by QS mutants or biofilms treated with inhibitors of QS were much more susceptible to the actions of these compounds (Davies et al. 1998; Hentzer et al. 2003; Rasmussen et al. 2005a,b; Bjarnsholt et al. 2005a; Dell’Acqua et al. 2004; Balaban et al. 2003a, 2004, 2005; Cirioni et al. 2003, 2006; Giacometti et al. 2003, 2005). These findings, in conjunction with the QS control of virulence factors, point out QS as a highly attractive target for chemotherapy against biofilm chronic infections!
References
Abraham WR (2006) Controlling biofilms of gram-positive pathogenic bacteria. Curr Med Chem 13:1509–1524
Adhikari RP, Arvidson S, Novick RP (2007) A nonsense mutation in agrA accounts for the defect in agr expression and the avirulence of Staphylococcus aureus 8325-4 traP::kan. Infect Immun 75:4534–4540
Anguita-Alonso P, Giacometti A, Cirioni O, Ghiselli R, Orlando F, Saba V, Scalise G, Sevo M, Patel R, Balaban N (2006) RNAIII-inhibiting peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation. Antimicrob Agents Chemother, Nov 20 (Epub ahead of print)
Ansaldi M, Marolt D, Stebe T, Mandic-Mulec I, Dubnau D (2002) Specific activation of the Bacillus quorum-sensing systems by isoprenylated pheromone variants. Mol Microbiol 44:1561–1573
Arvidson S, Tegmark K (2001) Regulation of virulence determinants in Staphylococcus aureus. Int J Med Microbiol 291:159–170
Atkinson S, Sockett RE, Camara M, Williams P (2006) Quorum sensing and the lifestyle of Yersinia. Curr Issues Mol Biol 8:1–10
Bae T, Banger AK, Wallace A, Glass EM, Aslund F, Schneewind O, Missiakas DM (2004) Staphylococcus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing. Proc Natl Acad Sci USA 101:12312–12317
Balaban N, Novick RP (1995a) Translation of RNAIII, the Staphylococcus aureus agr regulatory RNA molecule, can be activated by a 3′-end deletion. FEMS Microbiol Lett 133:155–161
Balaban N, Goldkorn T, Nhan RT, Dang LB, Scott S, Ridgley RM, Rasooly A, Wright SC, Larrick JW, Rasooly R, Carlson JR (1998) Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science 280:438–440
Balaban N, Collins LV, Cullor JS, Hume EB, Medina-Acosta E, Vieira-da-Motta O, O’Callaghan R, Rossitto PV, Shirtliff ME, Serafim da Silveira L, Tarkowski A, Torres JV (2000) Prevention of diseases caused by Staphylococcus aureus using the peptide RIP. Peptides 21:1301–1311
Balaban N, Goldkorn T, Gov Y, Hirshberg M, Koyfman N, Matthews HR, Nhan RT, Singh B, Uziel O (2001) Regulation of Staphylococcus aureus pathogenesis via target of RNAIII- activating protein (TRAP). J Biol Chem 276:2658–2667
Balaban N, Giacometti A, Cirioni O, Gov Y, Ghiselli R, Mocchegiani F, Viticchi C, Del Prete MS, Saba V, Scalise G, Dell’Acqua G (2003a) Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. J Infect Dis 187:625–630
Balaban N, Gov Y, Bitler A, Boelaert JR (2003b) Prevention of Staphylococcus aureus biofilm on dialysis catheters and adherence to human cells. Kidney Int 63:340–345
Balaban N, Gov Y, Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, Orlando F, D’Amato G, Saba V, Scalise G, Bernes S, Mor A (2004) A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. Antimicrob Agents Chemother 48:2544–2550
Balaban N, Stoodley P, Fux CA, Wilson S, Costerton JW, Dell’Acqua G (2005) Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP. Clin Orthop Relat Res 437:48–54
Bassler BL, Wright M, Showalter RE, Silverman MR (1993) Intercellular signalling in Vibrio harveyi: sequence and function of genes regulating expression of luminescence. Mol Microbiol 9:773–786
Beenken KE, Dunman PM, McAleese F, Macapagal D, Murphy E, Projan SJ, Blevins JS, Smeltzer MS (2004) Global gene expression in Staphylococcus aureus biofilms. J Bacteriol 186:4665–4684
Benito Y, Kolb FA, Romby P, Lina G, Etienne J, Vandenesch F (2000) Probing the structure of RNAIII, the Staphylococcus aureus agr regulatory RNA, and identification of the RNA domain involved in repression of protein A expression. RNA 6:668–679
Bjarnsholt T, Jensen PO, Burmolle M, Hentzer M, Haagensen JA, Hougen HP, Calum H, Madsen KG, Moser C, Molin S, Hoiby N, Givskov M (2005a) Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology 151:373–383
Blehert DS, Palmer RJ Jr, Xavier JB, Almeida JS, Kolenbrander PE (2003) Autoinducer 2 production by Streptococcus gordonii DL1 and the biofilm phenotype of a luxS mutant are influenced by nutritional conditions. J Bacteriol 185:4851–4860
Brito CF, Carvalho CB, Santos F, Gazzinelli RT, Oliveira SC, Azevedo V, Teixeira SM (2004) Chromobacterium violaceum genome:molecular mechanisms associated with pathogenicity. Genet Mol Res 3:148–161
Cassat J, Dunman PM, Murphy E, Projan SJ, Beenken KE, Palm KJ, Yang SJ, Rice KC, Bayles KW, Smeltzer MS (2006) Transcriptional profiling of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390. Microbiology 152:3075–3090
Charlton TS, de Nys R, Netting A, Kumar N, Hentzer M, Givskov M, Kjelleberg S (2000a) A novel and sensitive method for the quantification of N-3-oxoacyl homoserine lactones using gas chromatography-mass spectrometry: application to a model bacterial biofilm. Environ Microbiol 2:530–541
Chen X, Schauder S, Potier N, Dorsselaer AV, Pelczer I, Bassler BL, Hughson FM (2002) Structural identification of a bacterial quorum-sensing signal containing boron. Nature 415:545–549
Chhabra SR, Harty C, Hooi DS, Daykin M, Williams P, Telford G, Pritchard DI, Bycroft BW (2003) Synthetic analogues of the bacterial signal (quorum sensing) molecule N-(3-oxododecanoyl)-l-homoserine lactone as immune modulators. J Med Chem 46:97–104
Chien Y, Manna AC, Projan SJ, Cheung AL (1999) SarA, a global regulator of virulence determinants in Staphylococcus aureus, binds to a conserved motif essential for sar-dependent gene regulation. J Biol Chem 274:37169–37176
Choi SH, Greenberg EP (1991) The C-terminal region of the Vibrio fischeri LuxR protein contains an inducer-independent lux gene activating domain. Proc Natl Acad Sci USA 88:11115–11119
Christensen AB, Riedel K, Eberl L, Flodgaard LR, Molin S, Gram L, Givskov M (2003) Quorum-sensing-directed protein expression in Serratia proteamaculans B5a. Microbiology 149:471–483
Cirioni O, Giacometti A, Ghiselli R, Dell’Acqua G, Gov Y, Kamysz W, Lukasiak J, Mocchegiani F, Orlando F, D’Amato G, Balaban N, Saba V, Scalise G (2003) Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides. Circulation 108:767–771
Cirioni O, Giacometti A, Ghiselli R, Dell’acqua G, Orlando F, Mocchegiani F, Silvestri C, Licci A, Saba V, Scalise G, Balaban N (2006) RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. J Infect Dis 193:180–186
Cirioni O, Giacometti A, Ghiselli R, Kamysz W, Silvestri C, Orlando F, Mocchegiani F, Vittoria AD, Kamysz E, Saba V, Scalise G (2007) The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection. Peptides 28:1299–1303
Collier DN, Anderson L, McKnight SL, Noah TL, Knowles M, Boucher R, Schwab U, Gilligan P, Pesci EC (2002) A bacterial cell to cell signal in the lungs of cystic fibrosis patients. FEMS Microbiol Lett 215:41–46
Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322
Costerton JW, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G (2003) The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 112:1466–1477
Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP (1998) The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280:295–298
de Kievit TR, Iglewski BH (2000) Bacterial quorum sensing in pathogenic relationships. Infect Immun 68:4839–4849
de Kievit TR, Gillis R, Marx S, Brown C, Iglewski BH (2001) Quorum-sensing genes in Pseudomonas aeruginosa biofilms: their role and expression patterns. Appl Environ Microbiol 67:1865–1873
de Nys R, Wright AD, Konig GM, Sticher O (1993) New halogenated furanone from the marine alga Delisea pulchra (cf. fimbriata). Tetrahedron 49:11213–11220
Dell’Acqua G, Giacometti A, Cirioni O, Ghiselli R, Saba V, Scalise G, Gov Y, Balaban N (2004) Suppression of drug-resistant staphylococcal infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. J Infect Dis 190:318–320
Doherty N, Holden MT, Qazi SN, Williams P, Winzer K (2006) Functional analysis of luxS in Staphylococcus aureus reveals a role in metabolism but not quorum sensing. J Bacteriol 188:2885–2897
Donabedian H (2003) Quorum sensing and its relevance to infectious diseases. J Infect 46:207–214
Donlan RM (2002) Biofilms: microbial life on surfaces. Emerg Infect Dis 8:881–890
Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167–193
Dunman PM, Murphy E, Haney S, Palacios D, Tucker-Kellogg G, Wu S, Brown EL, Zagursky RJ, Shlaes D, Projan SJ (2001) Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J Bacteriol 183:7341–7353
Eberhard A, Burlingame AL, Eberhard C, Kenyon GL, Nealson KH, Oppenheimer NJ (1981) Structural identification of autoinducer of Photobacterium fishcheri luciferase. Biochemistry 20:2444–2449
Eberl L, Winson MK, Sternberg C, Stewart GS, Christiansen G, Chhabra SR, Bycroft B, Williams P, Molin S, Givskov M (1996) Involvement of N-acyl-L-homoserine lactone autoinducers in controlling the multicellular behaviour of Serratia liquefaciens. Mol Microbiol 20:127–136
Eberl L, Molin S, Givskov M (1999) Surface motility in Serratia liquefaciens. J Bacteriol 181:1703–1712
Egland KA, Greenberg EP (1999) Quorum sensing in Vibrio fischeri: elements of the luxl promoter. Mol Microbiol 31:1197–1204
Egland KA, Greenberg EP (2001) Quorum sensing in Vibrio fischeri: analysis of the LuxR DNA binding region by alanine-scanning mutagenesis. J Bacteriol 183:382–386
Finney AH, Blick RJ, Murakami K, Ishihama A, Stevens AM (2002) Role of the C-terminal domain of the alpha subunit of RNA polymerase in LuxR-dependent transcriptional activation of the lux operon during quorum sensing. J Bacteriol 184:4520–4528
Fukushima J, Ishiwata T, You Z, Ishii T, Shigematsu T, Kurata M, Chikumaru-Fujita S, Bycroft BW, Stewart GS, Kawamoto S, Morihara K, Williams P, Okuda K (1997) Dissection of the promoter/operator region and evaluation of N-acylhomoserine lactone mediated transcriptional regulation of elastase expression in Pseudomonas aeruginosa. FEMS Microbiol Lett 146:311–318
Fuqua C, Greenberg EP (2002) Signalling: listening in on bacteria: acyl-homoserine lactone signalling. Nat Rev Mol Cell Biol 3:685–695
Fuqua WC, Winans SC, Greenberg EP (1994) Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators. J Bacteriol 176:269–275
Gambello MJ, Iglewski BH (1991) Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression. J Bacteriol 173:3000–3009
Giacometti A, Cirioni O, Gov Y, Ghiselli R, Del Prete DS, Mocchegiani F, Saba V, Orlando F, Scalise G, Balaban N, Dell’Acqua G (2003) RNAIII inhibiting peptide (RIP) inhibits in vivo biofilm formation of drug-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47:1979–1983
Giacometti A, Cirioni O, Ghiselli R, Dell’Acqua G, Orlando F, D’Amato G, Mocchegiani F, Silvestri C, Del Prete MS, Rocchi M, Balaban N, Saba V, Scalise G (2005) RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. Peptides 26:169–175
Gonzalez Barrios AF, Zuo R, Hashimoto Y, Yang L, Bentley WE, Wood TK (2006) Autoinducer 2 controls biofilm formation in Escherichia coli through a novel motility quorum-sensing regulator (MqsR, B3022). J Bacteriol 188:305–316
Gov Y, Borovok I, Korem M, Singh VK, Jayaswal RK, Wilkinson BJ, Rich SM, Balaban N (2004) Quorum sensing in Staphylococci is regulated via phosphorylation of three conserved histidine residues. J Biol Chem 279:14665–14672
Gram L, Christensen AB, Ravn L, Molin S, Givskov M (1999) Production of acylated homoserine lactones by psychrotrophic members of the Enterobacteriaceae isolated from foods. Appl Environ Microbiol 65:3458–3463
Gray KM (1997) Intercellular communication and group behavior in bacteria. Trends Microbiol 5:184–188
Han YH, Kim YG, Kim DY, Ha SC, Lokanath NK, Kim KK (2005) The target of RNAIII-activating protein (TRAP) from Staphylococcus aureus: purification, crystallization and preliminary X-ray analysis. Biochim Biophys Acta 1748:134–136
Hanzelka BL, Greenberg EP (1995) Evidence that the N-terminal region of the Vibrio fischeri LuxR protein constitutes an autoinducer-binding domain. J Bacteriol 177:815–817
Hentzer M, Riedel K, Rasmussen TB, Heydorn A, Andersen JB, Parsek MR, Rice SA, Eberl L, Molin S, Høiby N, Kjelleberg S, Givskov M (2002) Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 148:87–102
Hentzer M, Wu H, Andersen JB, Riedel K, Rasmussen TB, Bagge N, Kumar N, Schembri MA, Song Z, Kristoffersen P, Manefield M, Costerton JW, Molin S, Eberl L, Steinberg P, Kjelleberg S, Høiby N, Givskov M (2003) Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J 22:3803–3815
Heydorn A, Ersboll B, Kato J, Hentzer M, Parsek MR, Tolker-Nielsen T, Givskov M, Molin S (2002) Statistical analysis of Pseudomonas aeruginosa biofilm development: impact of mutations in genes involved in twitching motility, cell-to-cell signaling, and stationary-phase sigma factor expression. Appl Environ Microbiol 68:2008–2017
Hoch JA, Varughese KI (2001) Keeping signals straight in phosphorelay signal transduction. J Bacteriol 183:4941–4949
Ji G, Beavis R, Novick RP (1997) Bacterial interference caused by autoinducing peptide variants. Science 276:2027–2030
Johansson J, Cossart P (2003) RNA-mediated control of virulence gene expression in bacterial pathogens. Trends Microbiol 11:280–285
Johnson DC, Ishihama A, Stevens AM (2003) Involvement of region 4 of the sigma70 subunit of RNA polymerase in transcriptional activation of the lux operon during quorum sensing. FEMS Microbiol Lett 228:193–201
Joyce EA, Kawale A, Censini S, Kim CC, Covacci A, Falkow S (2004) LuxS is required for persistent pneumococcal carriage and expression of virulence and biosynthesis genes. Infect Immun 72:2964–2975
Kjelleberg S, Molin S (2002) Is there a role for quorum sensing signals in bacterial biofilms? Curr Opin Microbiol 5:254–258
Kjelleberg S, Høiby N, Givskov M (2003) Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J 22:3803–3815
Koch B, Liljefors T, Persson T, Nielsen J, Kjelleberg S, Givskov M (2005) The LuxR receptor: the sites of interaction with quorum sensing signals and inhibitors. Microbiology 151:3589–3602
Koenig RL, Ray JL, Maleki SJ, Smeltzer MS, Hurlburt BK (2004) Staphylococcus aureus AgrA binding to the RNAIII-agr regulatory region. J Bacteriol 186:7549–7555
Korem M, Sheoran A, Gov Y, Borovok I, Tzipori S, Balaban N (2003) Characterization of RAP, a quorum sensing activator in Staphylococccus aureus. FEMS Microbiol Lett 223:167–175
Korem M, Gov Y, Kiran MD, Balaban N (2005) Transcriptional profiling of target of RNAIII-activating protein, a master regulator of staphylococcal virulence. Infect Immun 73:6220–6228
Kreikemeyer B, Boyle MD, Buttaro BA, Heinemann M, Podbielski A (2001) Group A streptococcal growth phase-associated virulence factor regulation by a novel operon (Fas) with homologies to two-component-type regulators requires a small RNA molecule. Mol Microbiol 39:392–406
Ledgham F, Ventre I, Soscia C, Foglino M, Sturgis JN, Lazdunski A (2003) Interactions of the quorum sensing regulator QscR: interaction with itself and the other regulators of Pseudomonas aeruginosa LasR and RhlR. Mol Microbiol 48:199–210
Lina G, Jarraud S, Ji G, Greenland T, Pedraza A, Etienne J, Novick RP, Vandenesch F (1998) Transmembrane topology and histidine protein kinase activity of AgrC, the agr signal receptor in Staphylococcus aureus. Mol Microbiol 28:655–662
Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339:520–532
Lyon GJ, Mayville P, Muir TW, Novick RP (2000) Rational design of a global inhibitor of the virulence response in Staphylococcus aureus, based in part on localization of the site of inhibition to the receptor-histidine kinase, AgrC. Proc Natl Acad Sci USA 97:13330–13335
Manna AC, Cheung AL (2003) sarU, a sarA homolog, is repressed by SarT and regulates virulence genes in Staphylococcus aureus. Infect Immun 71:343–353
March JC, Bentley WE (2004) Quorum sensing and bacterial cross-talk in biotechnology. Curr Opin Biotechnol 15:495–502
Mashburn LM, Whiteley M (2005) Membrane vesicles traffic signals and facilitate group activities in a prokaryote. Nature 437:422–425
Mashburn-Warren LM, Whiteley M (2006) Special delivery: vesicle trafficking in prokaryotes. Mol Microbiol 61:839–846
Mathesius U, Mulders S, Gao M, Teplitski M, Caetano-Anolles G, Rolfe BG, Bauer WD (2003) Extensive and specific responses of a eukaryote to bacterial quorum-sensing signals. Proc Natl Acad Sci USA 100:1444–1449
Mayville P, Ji G, Beavis R, Yang H, Goger M, Novick RP, Muir TW (1999) Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence. Proc Natl Acad Sci USA 96:1218–1223
McLean RJ, Whiteley M, Stickler DJ, Fuqua WC (1997) Evidence of autoinducer activity in naturally occurring biofilms. FEMS Microbiol Lett 154:259–263
Merritt J, Qi F, Goodman SD, Anderson MH, Shi W (2003) Mutation of luxS affects biofilm formation in Streptococcus mutans. Infect Immun 71:1972–1979
Michel A, Agerer F, Hauck CR, Herrmann M, Ullrich J, Hacker J, Ohlsen K (2006) Global regulatory impact of ClpP protease of Staphylococcus aureus on regulons involved in virulence, oxidative stress response, autolysis, and DNA repair. J Bacteriol 188:5783–5796
Miller MB, Bassler BL (2001) Quorum sensing in bacteria. Annu Rev Microbiol 55:165–199
Miller ST, Xavier KB, Campagna SR, Taga ME, Semmelhack MF, Bassler BL, Hughson FM (2004) Salmonella typhimurium recognizes a chemically distinct form of the bacterial quorum-sensing signal AI-2. Mol Cell 15:677–687
Mittal R, Sharma S, Chhibber S, Harjai K (2006) Contribution of quorum-sensing systems to virulence of Pseudomonas aeruginosa in an experimental pyelonephritis model. J Microbiol Immunol Infect 39:302–309
Morfeldt E, Taylor D, von Gabain A, Arvidson S (1995) Activation of alpha-toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII. EMBO J 14:4569–4577
Moser C, Johansen HK, Song Z, Hougen HP, Rygaard J, Hoiby N (1997) Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice. APMIS 105:838–842
Nakayama J, Cao Y, Horii T, Sakuda S, Nagasawa H (2001) Chemical synthesis and biological activity of the gelatinase biosynthesis-activating pheromone of Enterococcus faecalis and its analogs. Biosci Biotechnol Biochem 65:2322–2325
Novick RP (2003) Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 48:1429–1449
Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, Moghazeh S (1993) Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J 12:3967–3975
Novick RP, Projan SJ, Kornblum J, Ross HF, Ji G, Kreiswirth B, Vandenesch F, Moghazeh S (1995) The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus. Mol Gen Genet 248:446–458
Ochsner UA, Koch AK, Fiechter A, Reiser J (1994) Isolation and characterization of a regulatory gene affecting rhamnolipid biosurfactant synthesis in Pseudomonas aeruginosa. J Bacteriol 176:2044–2054
Otto M (2004) Quorum-sensing control in Staphylococci – a target for antimicrobial drug therapy? FEMS Microbiol Lett 241:135–141
Parsek MR, Greenberg EP (2000) Acyl-homoserine lactone quorum sensing in gram-negative bacteria: a signaling mechanism involved in associations with higher organisms. Proc Natl Acad Sci USA 97:8789–8793
Parsek MR, Singh PK (2003) Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 57:677–701
Parsek MR, Val DL, Hanzelka BL, Cronan JE, Greenberg EP (1999) Acyl homoserine-lactone quorum-sensing signal generation. Proc Natl Acad Sci USA 96:4360–4365
Pearson JP, Gray KM, Passador L, Tucker KD, Eberhard A, Iglewski BH, Greenberg EP (1994) Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes. Proc Natl Acad Sci USA 91:197–201
Pearson JP, Van Delden C, Iglewski BH (1999) Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals. J Bacteriol 181:1203–1210
Perraud AL, Weiss V, Gross R (1999) Signalling pathways in two-component phosphorelay systems. Trends Microbiol 7:115–120
Qiu R, Pei W, Zhang L, Lin J, Ji G (2005) Identification of the putative staphylococcal AgrB catalytic residues involving the proteolytic cleavage of AgrD to generate autoinducing peptide. J Biol Chem 280:16695–16704
Rasmussen TB, Bjarnsholt T, Skindersoe ME, Hentzer M, Kristoffersen P, Kote M, Nielsen J, Eberl L, Givskov M (2005a) Screening for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector. J Bacteriol 187:1799–1814
Rasmussen TB, Skindersoe ME, Bjarnsholt T, Phipps RK, Christensen KB, Jensen PO, Andersen JB, Koch B, Larsen TO, Hentzer M, Eberl L, Høiby N, Givskov M (2005b) Identity and effects of quorum-sensing inhibitors produced by Penicillium species. Microbiology 151:1325–1340
Ren D, Bedzyk LA, Thomas SM, Ye RW, Wood TK (2004b) Differential gene expression shows natural brominated furanones interfere with the autoinducer-2 bacterial signaling system of Escherichia coli. Biotechnol Bioeng 88:630–642
Ritchie AJ, Yam AO, Tanabe KM, Rice SA, Cooley MA (2003) Modification of in vivo and in vitro T- and B-cell-mediated immune responses by the Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)-l-homoserine lactone. Infect Immun 71:4421–4431
Rust L, Pesci EC, Iglewski BH (1996) Analysis of the Pseudomonas aeruginosa elastase (lasB) regulatory region. J Bacteriol 178:1134–1140
Schauder S, Shokat K, Surette MG, Bassler BL (2001) The LuxS-family of bacterial autoinducers: biosynthesis of a novel quorum-sensing signal molecule. Mol Microbiol 41:463–476
Shaw LN, Jonsson IM, Singh VK, Tarkowski A, Stewart GC (2007) Inactivation of traP has no effect on the agr quorum-sensing system or virulence of Staphylococcus aureus. Infect Immun 75:4519–4527
Sheng J, Citovsky V (1996) Agrobacterium-plant cell DNA transport: have virulence proteins, will travel. Plant Cell 8:1699–1710
Shimizu T, Yaguchi H, Ohtani K, Banu S, Hayashi H (2002) Clostridial VirR/VirS regulon involves a regulatory RNA molecule for expression of toxins. Mol Microbiol 43:257–265
Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP (2000) Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407:762–764
Smith RS, Iglewski BH (2003) P. aeruginosa quorum-sensing systems and virulence. Curr Opin Microbiol 6:56–60
Smith RS, Harris SG, Phipps R, Iglewski B (2002a) The Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl) homoserine lactone contributes to virulence and induces inflammation in vivo. J Bacteriol 184:1132–1139
Smith RS, Kelly R, Iglewski BH, Phipps RP (2002b) The Pseudomonas autoinducer N-(3-oxododecanoyl) homoserine lactone induces cyclooxygenase-2 and prostaglandin E2 production in human lung fibroblasts:implications for inflammation. J Immunol 169:2636–2642
Sperandio V, Mellies JL, Nguyen W, Shin S, Kaper JB (1999) Quorum sensing controls expression of the type III secretion gene transcription and protein secretion in enterohemorhagic and enteropathogenic Escherichia coli. Proc Natl Acad Sci USA 96:15196–15201
Sperandio V, Torres AG, Jarvis B, Nataro JP, Kaper JB (2003) Bacteria-host communication: the language of hormones. Proc Natl Acad Sci USA 100:8951–8956
Telford G, Wheeler D, Williams P, Tomkins PT, Appleby P, Sewell H, Stewart GS, Bycroft BW, Pritchard DI (1998) The Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-l-homoserine lactone has immunomodulatory activity. Infect Immun 66:36–42
Trott AE, Stevens AM (2001) Amino acid residues in LuxR critical for its mechanism of transcriptional activation during quorum sensing in Vibrio fischeri. J Bacteriol 183:387–392
Tsang LH, Daily ST, Weiss EC, Smeltzer MS (2007) Mutation of traP in Staphylococcus aureus has no impact on expression of agr or biofilm formation. Infect Immun 75:4528–4533
Vannini A, Volpari C, Gargioli C, Muraglia E, Cortese R, De Francesco R, Neddermann P, Marco SD (2002) The crystal structure of the quorum sensing protein TraR bound to its autoinducer and target DNA. EMBO J 21:4393–4401
Velicer GJ (2003) Social strife in the microbial world. Trends Microbiol 11:330–337
Vendeville A, Winzer K, Heurlier K, Tang CM, Hardie KR (2005) Making “sense” of metabolism:autoinducer-2, LuxS and pathogenic bacteria. Nat Rev Microbiol 3:383–396
Vieira-da-Motta O, Damasceno Ribeiro P, Dias da Silva W, Medina-Acosta E (2001) RNAIII inhibiting peptide (RIP) inhibits agr-regulated toxin production. Peptides 22:1621–1627
Vuong C, Saenz HL, Gotz F, Otto M (2000) Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J Infect Dis 182:1688–1693
Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M (2003) Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J Infect Dis 188:706–718
Wagner VE, Bushnell D, Passador L, Brooks AI, Iglewski BH (2003) Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment. J Bacteriol 185:2080–2095
Walters M, Sperandio V (2006) Autoinducer 3 and epinephrine signaling in the kinetics of locus of enterocyte effacement gene expression in enterohemorrhagic Escherichia coli. Infect Immun 74:5445–5455
Waters CM, Bassler BL (2005) Quorum sensing: cell-to-cell communication in bacteria. Annu Rev Cell Dev Biol 21:319–346
Watson WT, Minogue TD, Val DL, von Bodman SB, Churchill ME (2002) Structural basis and specificity of acyl-homoserine lactone signal production in bacterial quorum sensing. Mol Cell 9:685–694
Whitehead NA, Byers JT, Commander P, Corbett MJ, Coulthurst SJ, Everson L, Harris AK, Pemberton CL, Simpson NJ, Slater H, Smith DS, Welch M, Williamson N, Salmond GP (2002) The regulation of virulence in phytopathogenic Erwinia species: quorum sensing, antibiotics and ecological considerations. Antonie Van Leeuwenhoek 81:223–231
Whiteley M, Greenberg EP (2001) Promoter specificity elements in Pseudomonas aeruginosa quorum-sensing-controlled genes. J Bacteriol 183:5529–5534
Winans SC, Bassler BL (2002) Mob psychology. J Bacteriol 184:873–883
Winzer K, Williams P (2001) Quorum sensing and the regulation of virulence gene expression in pathogenic bacteria. Int J Med Microbiol 291:131–143
Withers H, Swift S, Williams P (2001) Quorum sensing as an integral component of gene regulatory networks in Gram-negative bacteria. Curr Opin Microbiol 4:186–193
Wopperer J, Cardona ST, Huber B, Jacobi CA, Valvano MA, Eberl L (2006) A quorum-quenching approach to investigate the conservation of quorum-sensing-regulated functions within the Burkholderia cepacia complex. Appl Environ Microbiol 72:1579–1587
Xavier KB, Bassler BL (2005) Regulation of uptake and processing of the quorum-sensing autoinducer AI-2 in Escherichia coli. J Bacteriol 187:238–248
Yang G, Cheng H, Liu C, Xue Y, Gao Y, Liu N, Gao B, Wang D, Li S, Shen B, Shao N (2003) Inhibition of Staphylococcus aureus pathogenesis in vitro and in vivo by RAP-binding peptides. Peptides 24:1823–1828
Yang G, Gao Y, Dong J, Liu C, Xue Y, Fan M, Shen B, Shao N (2005) A novel peptide screened by phage display can mimic TRAP antigen epitope against Staphylococcus aureus infections. J Biol Chem 280:27431–27435
Zhang L, Ji G (2004) Identification of a staphylococcal AgrB segment(s) Responsible for group-specific processing of AgrD by gene swapping. J Bacteriol 186:6706–6713
Zhang L, Gray L, Novick RP, Ji G (2002a) Transmembrane topology of AgrB, the protein involved in the post-translational modification of AgrD in Staphylococcus aureus. J Biol Chem 277:34736–34742
Zhang RG, Pappas T, Brace JL, Miller PC, Oulmassov T, Molyneaux JM, Anderson JC, Bashkin JK, Winans SC, Joachimiak A (2002b) Structure of a bacterial quorum-sensing transcription factor complexed with pheromone and DNA. Nature 417:971–974
Ziebandt AK, Weber H, Rudolph J, Schmid R, Hoper D, Engelmann S, Hecker M (2001) Extracellular proteins of Staphylococcus aureus and the role of SarA and sigma B. Proteomics 1:480–493
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Givskov, M., Rasmussen, T.B., Ren, D., Balaban, N. (2008). Bacterial Cell-to-cell Communication (Quorum Sensing). In: Balaban, N. (eds) Control of Biofilm Infections by Signal Manipulation. Springer Series on Biofilms, vol 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/7142_2007_007
Download citation
DOI: https://doi.org/10.1007/7142_2007_007
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-73852-7
Online ISBN: 978-3-540-73853-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)